Metraipolis › archive › dc_fc2fd758ad7c

Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention? — Europe PMC PMID:42125229

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125229
DOI
10.3389/fendo.2026.1813342
License (as archived)
solo-consultazione
Archived
2026-11-03T03:15:54.709Z
SHA-256 of the archived text
c59ed9cb37a1198ba18c8942d14bb4256a460d2cfd4f9ffbaa84b4a84e3d77df
Stable URL of this page
https://metraipolis.com/documento/dc_fc2fd758ad7c

How to cite

Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention? — Europe PMC PMID:42125229 — Europe PMC (en), https://europepmc.org/article/MED/42125229 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc2fd758ad7c (Metraipolis archive dc_fc2fd758ad7c, sha256 c59ed9cb37a1198ba18c8942d14bb4256a460d2cfd4f9ffbaa84b4a84e3d77df)
BibTeX
@misc{dcfc2fd758ad7c,
  title = {Why does LDL-C follow a different paradigm from other endocrine-metabolic diseases in cardiovascular prevention? — Europe PMC PMID:42125229},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125229},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc2fd758ad7c; sha256 c59ed9cb37a1198ba18c8942d14bb4256a460d2cfd4f9ffbaa84b4a84e3d77df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125229. Agents can read the archived copy with the MCP tool read_document.